Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green for NIR Image-Guided Surgery in Head and Neck Cancer
NCT03745690Phase 2Withdrawn
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Dec 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in head and neck carcinoma (HNC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Planned start Dec 2018; status: withdrawn.
02
Drugs
indocyanine green
03
Conditions
head and neck carcinoma (HNC)
Beyond the preview
Go deeper on NCT03745690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745690.